Computed tomography during hepatic arteriography pattern may predict hepatocellular carcinoma recurrence following transarterial chemoembolization
Kazuhiro Katayama, Katsuyuki Nakanishi(The University of Osaka), Mitsuru Sakakibara(The University of Osaka), Kazuyoshi Ohkawa(Osaka International Cancer Institute), Takashi Matsunaga(Shiga University of Medical Science), Tetsuro Nakazawa(Osaka International Cancer Institute), Masanori Miyazaki(The Graduate University for Advanced Studies, SOKENDAI), Masayuki Murata(Kyushu University), Akio Ishihara(Osaka National Hospital), Kazuho Imanaka(Osaka International Cancer Institute), Haruki Kimura(Osaka International Cancer Institute)
Cited by 2
Related Papers
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma
|European Journal of Cancer|2011|573
Validation of A New Prognostic Staging System for Hepatocellular Carcinoma: the Jis Score Compared With the Clip Score
|Hepatology|2004|359
Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines)
|Hepatology Research|2023|281
Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis
|Journal of Gastroenterology|2009|205
Whole-body MRI for Detecting Metastatic Bone Tumor: Diagnostic Value of Diffusion-weighted Images
|Magnetic Resonance in Medical Sciences|2007|181